towfiqu-barbhuiya-msQB97gUxY0-unsplash.jpg
News Article
Patient-accessible medical devices can influence health outcomes.
Merck-IMG-2021-Alfredo-Román-1-MBN-mbn
View from the Top
Alfredo Román
Director of the Fertility Unit
Merck Group México
Merck’s new fertility treatment device improves comfort and is easier to use than conventional methods, which should improve patient adherence.
julia-zolotova-5ZofAm1f27E-unsplash
News Article
Pharmaceutical companies are developing oral treatments and vaccines to fight the COVID-19 pandemic.
Pfizer's Toluca Plant
News Article
Pfizer continues moving forward with its COVID-19 treatment, following the UK’s MHRA emergency use authorization of Merck’s molnupiravir.
Pills, medicines
News Article
The UK’s MHRA approved molnupiravir, the first COVID-19 oral treatment, for its emergency use.
Pills, medicines
News Article
Generic drugmakers are expected to market molnupiravir for US$20 per treatment, compared to the US$712 that the US government agreed to pay Merck.
melany-tuinfosalud-com-X9MgAxJX8eU-unsplash
Weekly Roundups
Health budgets, medicine distribution and market changes are discussed in this week’s roundup.
Pills, medicines
News Article
An interim analysis indicated that Merck’s molnupiravir halves the chances of dying or being hospitalized for severe COVID-19 illness.
Pills, medicines
News Article
Drugmakers continue their efforts to offer end-to-end treatment options for COVID-19 patients.
Subscribe to Merck